Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Nitroglycerin
Drug ID BADD_D01579
Description Nitroglycerin is a vasodilator drug used for the treatment of chest pain and high blood pressure.[T628,L4429] It was first approved in 2000 and is currently marketed by Pfizer, and other companies, depending on the dosage form.[T628,L4894] Nitroglycerin is available in various forms, including a spray form, sublingual tablet form, intravenous form, extended-release tablet form, and transdermal form. A less commonly known fact is that in addition to treating angina, nitroglycerin is also used in an ointment to treat the pain that accompanies anal fissures. The rectal ointment form of nitroglycerin was approved by the FDA in 1955.[L7096]
Indications and Usage Nitroglycerin is indicated for various purposes.[L4894] It is indicated to prevent and treat angina or chest pain due to cardiovascular disease, as well as to treat peri-operative hypertension or induce intra-operative hypotension.[L4429,L7099] It is also indicated to treat acute heart failure in patients with myocardial infarction.[L7099] In the ointment form, nitroglycerin is indicated to treat pain caused by anal fissures.[L7096] The transdermal form is applied directly to the skin to prevent acute anginal attacks.[L7141] The intravenous form is used off-label in emergency settings and is commonly used to treat acute coronary spasm caused by cocaine, hypertensive emergencies, as well as acute congestive heart failure exacerbations.[T628] Some other off-label uses of nitroglycerin include management of variceal hemorrhage[A180280], management of esophageal spasticity[A180283], and induction of uterine relaxation.[A180277]
Marketing Status approved; investigational
ATC Code C05AE01; C01DA02
DrugBank ID DB00727
KEGG ID D00515
MeSH ID D005996
PubChem ID 4510
TTD Drug ID D07YDE
NDC Product Code 47781-457; 47781-458; 50742-513; 59762-3304; 63629-8830; 0378-9104; 0378-9116; 68428-407; 70710-1019; 70771-1718; 70771-1719; 43598-895; 45802-210; 49483-221; 50090-4874; 52584-418; 0338-1047; 68428-100; 71205-482; 71872-7010; 28595-120; 51662-1351; 51662-1386; 0404-9928; 68071-2260; 68071-2941; 68462-640; 70518-0545; 59762-0489; 0338-1051; 63629-8829; 68428-050; 70710-1018; 72888-138; 43598-435; 43598-436; 47781-456; 49483-223; 50742-518; 51662-1244; 52584-810; 60429-839; 0404-9929; 69339-173; 71872-7201; 72888-139; 43598-893; 50090-0332; 0220-2291; 50742-516; 60429-840; 60429-841; 68462-638; 72888-140; 0071-0417; 0071-0418; 43598-896; 58914-301; 63187-884; 0378-9112; 70771-1717; 71205-225; 0071-0419; 50090-3266; 50742-514; 50742-515; 0338-1049; 63629-8828; 69339-174; 70710-1020; 71872-7300; 0220-2283; 51662-1282; 51662-1340; 64117-543; 68462-639; 69339-175; 0517-4810; 28595-550; 43598-437; 43598-894; 49483-222; 50742-517; 0378-9102; 71872-7033; 0281-0326; 59762-4921
UNII G59M7S0WS3
Synonyms Nitroglycerin | Glyceryl Trinitrate | Trinitrate, Glyceryl | Nitrolan | Nitrospan | Nitrostat | Perlinganit | Nitrong | Susadrin | Sustac | Sustak | Sustonit | Transderm Nitro | Nitroglyn | Trinitrin | Trinitrolong | Anginine | Dynamite | Gilustenon | Nitrangin | Nitro-Bid | Nitro Bid | NitroBid | Nitro-Dur | Nitro Dur | NitroDur | Nitrocard | Nitroderm | Nitroderm TTS | Nitrol | Tridil
Chemical Information
Molecular Formula C3H5N3O9
CAS Registry Number 55-63-0
SMILES C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Cardiopulmonary failure22.02.06.004; 02.05.01.0040.000065%Not Available
Acute coronary syndrome24.04.04.011; 02.02.02.0150.000065%Not Available
Necrotising colitis07.08.01.013--Not Available
Lymphatic disorder01.09.01.003--Not Available
Drug tolerance08.06.01.003--Not Available
Skin swelling23.03.03.039--Not Available
Clonic convulsion17.12.03.008--Not Available
Application site swelling12.07.01.027; 08.02.01.027--Not Available
Skin burning sensation23.03.03.021; 17.02.06.009--Not Available
Hypoaesthesia oral17.02.06.021; 07.05.05.0030.000142%Not Available
Paraesthesia oral07.05.05.035; 17.02.06.0080.000471%Not Available
Lung neoplasm malignant22.08.01.001; 16.19.02.001--Not Available
Vasodilation procedure25.03.01.001--Not Available
Angiopathy24.03.02.007--Not Available
Hot flush21.02.02.001; 24.03.01.005; 08.01.03.0270.000065%
Adverse event08.06.01.010--Not Available
Cardiac disorder02.11.01.003--Not Available
Infestation23.11.01.002; 11.09.01.001--Not Available
Limb discomfort15.03.04.0140.000065%Not Available
Ischaemia24.04.02.0040.000097%Not Available
Mediastinal disorder22.09.03.001--Not Available
Mental disorder19.07.01.002--Not Available
Blood disorder01.05.01.004--Not Available
Drug intolerance08.06.01.0130.000581%Not Available
Poor quality sleep19.02.05.005; 17.15.04.002--Not Available
Application site burn23.03.11.013; 12.07.01.038; 08.02.01.0380.000284%Not Available
Acute kidney injury20.01.03.016--
Posterior reversible encephalopathy syndrome17.13.02.0070.000065%
Burning sensation mucosal08.01.06.020; 17.02.06.031--Not Available
Ventricular asystole02.03.04.0180.000065%Not Available
The 7th Page    First    Pre   7 8    Next   Last    Total 8 Pages